STAT+: Older GLP-1 drug may help protect brains of Alzheimer’s patients, early study suggests
A new study suggests that an older GLP-1 drug may help protect the brains of…
A new study suggests that an older GLP-1 drug may help protect the brains of…
Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the…
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Eli Lilly’s early Alzhiemer’s treatment was approved by the Food and Drug Administration on Tuesday,…
A Cassava Sciences collaborator and paid consultant has been indicted by a federal grand jury…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
When the results of President Biden’s annual physical were released last month, many wondered why…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
An experimental treatment for Alzheimer’s disease that removes a toxic protein called tau from brain…